| __timestamp | Alpine Immune Sciences, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 4534000000 |
| Thursday, January 1, 2015 | 16054000 | 5920000000 |
| Friday, January 1, 2016 | 23316000 | 4940000000 |
| Sunday, January 1, 2017 | 10626000 | 6411000000 |
| Monday, January 1, 2018 | 28970000 | 6345000000 |
| Tuesday, January 1, 2019 | 35847000 | 6148000000 |
| Wednesday, January 1, 2020 | 27185000 | 11143000000 |
| Friday, January 1, 2021 | 58742000 | 10195000000 |
| Saturday, January 1, 2022 | 70243000 | 9509000000 |
| Sunday, January 1, 2023 | 80904000 | 9299000000 |
| Monday, January 1, 2024 | 11159000000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology and pharmaceuticals, research and development (R&D) investments are pivotal. Over the past decade, Bristol-Myers Squibb Company and Alpine Immune Sciences, Inc. have demonstrated contrasting scales of investment in R&D. Bristol-Myers Squibb, a titan in the pharmaceutical industry, has consistently invested heavily, with expenditures peaking at approximately $11 billion in 2020. This represents a staggering 145% increase from 2014. In contrast, Alpine Immune Sciences, a smaller biotech firm, has shown a remarkable growth trajectory, with R&D spending increasing by over 560% from 2014 to 2023. Despite the disparity in absolute numbers, both companies underscore the critical role of R&D in driving innovation and maintaining competitive advantage. As the industry continues to advance, these investments will likely shape the future of healthcare and therapeutic solutions.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.